HIGHLIGHTS
- who: Sian M. Noble from the University of Oxford, Oxford, UK have published the research work: The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer, in the Journal: (JOURNAL) of 25/06/2020
- what: The trial database containing some clinical information was used for validation purposes. This study shows that at a median 10 years this was not the case.
- how: This paper presents an individual patient data economic evaluation of the ProtecT trial in terms of costs to the UK NHS and Quality-Adjusted-Life . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.